Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $67.7 million.

  • Tandem Diabetes Care's Shares Outstanding (Weighted Average) rose 322.56% to $67.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.7 million, marking a year-over-year increase of 322.56%. This contributed to the annual value of $65.9 million for FY2024, which is 87.2% up from last year.
  • Tandem Diabetes Care's Shares Outstanding (Weighted Average) amounted to $67.7 million in Q3 2025, which was up 322.56% from $67.0 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Shares Outstanding (Weighted Average) registered a high of $67.7 million during Q3 2025, and its lowest value of $62.4 million during Q1 2021.
  • In the last 5 years, Tandem Diabetes Care's Shares Outstanding (Weighted Average) had a median value of $64.8 million in 2023 and averaged $64.8 million.
  • In the last 5 years, Tandem Diabetes Care's Shares Outstanding (Weighted Average) skyrocketed by 453.3% in 2021 and then skyrocketed by 50.9% in 2024.
  • Over the past 5 years, Tandem Diabetes Care's Shares Outstanding (Weighted Average) (Quarter) stood at $63.0 million in 2021, then increased by 1.82% to $64.1 million in 2022, then rose by 1.91% to $65.4 million in 2023, then rose by 0.87% to $65.9 million in 2024, then rose by 2.6% to $67.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $67.7 million in Q3 2025, compared to $67.0 million in Q2 2025 and $66.4 million in Q1 2025.